Business Context and Reporting Period
This Form 6-K filing by Guardforce AI Co., Limited covers the month of May 2023. The report details the entry into a Material Definitive Agreement regarding an underwritten public offering of ordinary shares, which closed on May 15, 2023.
Key Financial Metrics
- Gross Proceeds: Approximately $13.8 million (including full exercise of the over-allotment option).
- Net Proceeds: Approximately $12.68 million after deducting underwriting discounts, non-accountable expense allowances, and offering expenses.
- Shares Issued: 2,580,600 ordinary shares initially, plus 387,090 over-allotment shares, totaling 2,967,690 shares.
- Offering Price: $4.65 per share.
- Underwriting Fees: 7.0% of gross proceeds plus 0.5% for non-accountable expenses, plus capped expenses up to $80,000.
Material Changes
The primary material change is the successful completion of a capital raise. The company initially announced an offering for approximately $12.0 million. On May 12, 2023, the underwriters exercised the over-allotment option in full, increasing the total gross proceeds to approximately $13.8 million. This transaction significantly increased the company's cash liquidity compared to the pre-offering period.
Outlook, Management Commentary, and Risks
- Use of Proceeds: Management intends to utilize net proceeds for research and development to advance AI and robotic capabilities, business development (sales, marketing, expansion), talent recruitment, and general working capital.
- Lock-Up Period: The company agreed to a 180-day lock-up period following the closing, restricting the sale or disposal of ordinary shares by the company and certain holders, subject to exceptions and the representative's discretion to release securities.
- Risks: The filing notes standard securities law restrictions regarding offers in jurisdictions where registration is not complete.
Investor Verification Checklist
- Verify the final net cash proceeds of $12.68 million against the company's balance sheet in the next quarterly or annual report.
- Confirm the allocation of funds to R&D and business development as stated in the use of proceeds section.
- Monitor the 180-day lock-up period expiration date for potential increases in share supply.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and conditions not detailed in this summary.